Raymond James Trust’s Moderna MRNA Stock Holding History

Raymond James Trust’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,590	Closed	-$308K	–	1337
2024 Q2	$308K	Buy	2,590 +602	+30%	+$76.2K	0.01%	970
2024 Q1	$212K	Buy	+1,988	New	+$200K	0.01%	1165
2023 Q2	–	Sell	-1,480	Closed	-$228K	–	1201
2023 Q1	$228K	Buy	+1,480	New	+$244K	0.01%	1007
2022 Q1	–	Sell	-893	Closed	-$227K	–	1198
2021 Q4	$227K	Sell	893 -2,348	-72%	-$687K	0.01%	1039
2021 Q3	$1.25M	Buy	+3,241	New	+$1.2M	0.04%	341

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Raymond James Trust's MRNA Position: Q3 2024 in Review

Raymond James Trust sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,590 shares — an estimated $308K sold.

Raymond James Trust first reported a position in MRNA in Q3 2021 and held it in 5 quarters. The position peaked at $1.25M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

Raymond James Trust reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
Raymond James Trust sold 2,590 Moderna shares in Q3 2024, an estimated $308K.
Raymond James Trust first reported a position in Moderna in Q3 2021 and held it in 5 quarters.
Raymond James Trust's Moderna position peaked at $1.25M in Q3 2021.
788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.